Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 19/20 | 0.52 |
| ▸ | THRA | P10827 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.51 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.51 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4414166 | 0.84 | EGLN1 (0.50) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL4407707 | 0.83 | EGLN1 (0.54) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL4755239 | 0.81 | EGLN1 (0.58) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL4418148 | 0.81 | EGLN1 (0.52) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL3924454 | 0.81 | EGLN1 (0.65) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL4411746 | 0.80 | EGLN1 (0.61) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL4408921 | 0.79 | EGLN1 (0.49) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL5318572 | 0.79 | EGLN1 (0.50) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL523120 | 0.77 | EGLN1 (0.67) | EGLN1THRATHRBFTOBBOX1 | |
| SCHEMBL522338 | 0.77 | EGLN1 (0.60) | EGLN1THRATHRBFTOBBOX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008040002-A9 | METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR HIF MODULATING COMPOUNDS | HUTCHINSON FRED CANCER RES (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009002533-A1 | INFLAMMATORY BOWEL DISEASE THERAPIES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008040002-A2 | METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR HIF MODULATING COMPOUNDS | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2008-04-03 | — | — | WO | disclosed |
| WO-2007047194-A2 | METHODS FOR TREATING MITF-RELATED DISORDERS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2007-04-26 | — | — | WO | disclosed |